The efficacy and mechanism evaluation of treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole (EME-TIPAC)

Wilson, Andrew (Principal Investigator)
Clark, Allan (Co-Investigator)
Fraser, William (Co-Investigator)
Livermore, David (Co-Investigator)
Swart, Ann Marie (CTU Role)

Status	Finished
Effective start/end date	1/12/14 → 30/11/19

Funding

National Institute for Health and Care Research: £1,402,428.00

1 Article

The efficacy and mechanism evaluation of treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial
Hammond, M., Clark, A. B., Cahn, A. P., Chilvers, E. R., Fraser, W. D., Livermore, D. M., Maher, T. M., Parfrey, H., Swart, A. M., Stirling, S., Thickett, D., Whyte, M. & Wilson, A., 5 Feb 2018, In: Trials. 19, 89.
Research output: Contribution to journal › Article › peer-review

Open Access
File

19 Citations (Scopus)

21 Downloads (Pure)